<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00801741163821</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U41301H4</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.727Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741158766</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U410074</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741156915</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8130710</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.687Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741158995</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4200715</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.669Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741156441</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8200522</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741156564</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U815068</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741162930</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4200525</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.620Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741165481</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U890330</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.595Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741053856</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U41303H4</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.554Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741055072</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U875422</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.534Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741158087</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4150420</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.514Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741164309</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8100310</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.494Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741156373</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8200510</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.472Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741124563</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4100330</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.448Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741064524</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4150415</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741054754</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U875322</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.411Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741164651</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8100515</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741064562</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4150515</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.374Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741064722</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U8150215</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.359Z</lastUpdated>
  </row>
  <row>
    <udiDi>00801741159121</udiDi>
    <basicUdiDi>0801741OVDRDUTB5M</basicUdiDi>
    <tradeName>ULTRAVERSE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bard Peripheral Vascular, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017556</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U4150730</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-22T00:14:06.343Z</lastUpdated>
  </row>
</eudamedExport>